Zhou Hui, Sim John J, Bhandari Simran K, Shaw Sally F, Shi Jiaxiao, Rasgon Scott A, Kovesdy Csaba P, Kalantar-Zadeh Kamyar, Kanter Michael H, Jacobsen Steven J
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.
Kidney Int Rep. 2018 Oct 16;4(2):275-284. doi: 10.1016/j.ekir.2018.10.008. eCollection 2019 Feb.
Lower early mortality observed in peritoneal dialysis (PD) compared with hemodialysis (HD) may be due to differential pre-end-stage renal disease (ESRD) care and the stable setting of transition to dialysis where PD starts are more frequently outpatient rather than during an unscheduled hospitalization. To account for these circumstances, we compared early mortality among a matched cohort of PD and HD patients who had optimal and outpatient starts.
Retrospective cohort study performed among patients with chronic kidney disease (CKD) who transitioned to ESRD from 1 January 2002 to 31 March 2015 with an optimal start in an outpatient setting. Optimal start defined as (i) HD with an arteriovenous graft or fistula or (ii) PD. Propensity score modeling factoring age, race, sex, comorbidities, estimated glomerular filtration rate (eGFR) level, and change in eGFR before ESRD was used to create a matched cohort of HD and PD. All-cause mortality was compared at 6 months, 1 year, and 2 years posttransition to ESRD.
Among 2094 patients (1398 HD and 696 PD) who had optimal outpatient transition to ESRD, 541 HD patients were propensity score-matched to 541 PD patients (caliper distance <0.001). All-cause mortality odds ratios (OR) in PD compared with HD were 0.79 (0.39-1.63), 0.73 (0.43-1.23), and 0.88 (0.62-1.26) for 6 months, 1 year, and 2 years, respectively. Time-varying analysis accounting for modality switch (19% PD, 1.9% HD) demonstrated a mortality hazard ratio of 0.94 (0.70-1.24).
Among an optimal start CKD cohort that transitioned to ESRD on an outpatient basis, we found no evidence of differences in early mortality between PD and HD.
与血液透析(HD)相比,腹膜透析(PD)早期死亡率较低,这可能归因于终末期肾病(ESRD)前期护理的差异,以及向透析过渡时的稳定环境,即PD开始时更多是门诊透析而非计划外住院期间透析。为考虑这些情况,我们比较了一组匹配的、开始透析时情况最佳且为门诊透析的PD和HD患者的早期死亡率。
对2002年1月1日至2015年3月31日从慢性肾脏病(CKD)转变为ESRD且在门诊环境中开始透析情况最佳的患者进行回顾性队列研究。最佳开始定义为:(i)使用动静脉移植物或内瘘进行HD,或(ii)进行PD。采用倾向评分模型,将年龄、种族、性别、合并症、估计肾小球滤过率(eGFR)水平以及ESRD前eGFR的变化作为因素,以创建HD和PD的匹配队列。比较转变为ESRD后6个月、1年和2年时的全因死亡率。
在2094例(1398例HD和696例PD)以最佳门诊方式转变为ESRD的患者中,541例HD患者与541例PD患者进行了倾向评分匹配(卡尺距离<0.001)。PD组与HD组相比,6个月、1年和2年时的全因死亡比值比(OR)分别为0.79(0.39 - 1.63)、0.73(0.43 - 1.23)和0.88(0.62 - 1.26)。考虑到透析方式转换(19%的PD患者,1.9%的HD患者)的时间变化分析显示,死亡风险比为0.94(0.70 - 1.24)。
在一组以最佳方式开始透析且在门诊转变为ESRD的CKD队列中,我们未发现PD和HD在早期死亡率方面存在差异的证据。